Extended-release niacin acutely suppresses postprandial triglyceridemia

American Journal of Medicine

Volumn 125, Issue 10, 2012, Pages 1026-1035

  Usman, M Haris U ^a,b   Qamar, Arman ^a   Gadi, Ramprasad ^d   Lilly, Scott ^b,c   Goel, Harsh ^a   Hampson, Jaison ^a   Mucksavage, Megan L ^a   Nathanson, Grace A ^a   Rader, Daniel J ^a,b,c   Dunbar, Richard L ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EINSTEIN MEDICAL CENTER   (United States)

^d YORK HOSPITAL   (United States)

Author keywords

Adult; African Americans; Clinical trial; Dietary fats; Drug; Evaluation; Free fatty acids; Humans; Hydroxybutyrate; Ketones; Lipids; Lipoprotein; Niacin; Niacin pharmacology; Niacin therapeutic use; Postprandial; Randomized controlled trial; Triglycerides

Indexed keywords

FATTY ACID; HYDROXYBUTYRIC ACID; NICOTINIC ACID; PLACEBO; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RELEASE; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; LIPID DIET; POSTPRANDIAL TRIGLCERIDEMIA; POSTPRANDIAL TRIGLYCERIDEMIA; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AFRICAN AMERICANS; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; NIACIN; POSTPRANDIAL PERIOD; REGRESSION ANALYSIS; ROC CURVE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84866505413     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.03.017     Document Type: Article

References (51)

1. N. Sarwar, J. Danesh, G. Eiriksdottir Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies Circulation 115 2007 450 458
2. J.E. Hokanson, M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 1996 213 219
3. B.G. Nordestgaard, M. Benn, P. Schnohr, A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
4. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316
5. A.R. Sharrett, L.E. Chambless, G. Heiss, C.C. Paton, W. Patsch Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol 15 1995 2122 2129
6. J.E. Ryu, G. Howard, T.E. Craven, M.G. Bond, A.P. Hagaman, J.R. Crouse III Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects Stroke 23 1992 823 828
7. S. Boquist, G. Ruotolo, R. Tang Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men Circulation 100 1999 723 728
8. R.A. Vogel, M.C. Corretti, G.D. Plotnick Effect of a single high-fat meal on endothelial function in healthy subjects Am J Cardiol 79 1997 350 354
9. G.D. Kolovou, P.M. Kostakou, K.K. Anagnostopoulou, D.V. Cokkinos Therapeutic effects of fibrates in postprandial lipemia Am J Cardiovasc Drugs 8 2008 243 255
10. G.D. Kolovou, K.K. Anagnostopoulou, K.D. Salpea, S.S. Daskalopoulou, D.P. Mikhailidis The effect of statins on postprandial lipemia Curr Drug Targets 8 2007 551 560
11. E.A. Nikkila Effect of nicotinic acid on adipose lipoprotein lipase and removal rate of plasma triglycerides K.F. Gey, L.A. Carlson, Metabolic Effects of Nicotinic Acid and its Derivatives 1971 Hanss Huber Publishers Bern 487 496
12. S. Froberg, J. Boberg, L.A. Carlson, M. Eriksson Effect of nicotinic acid on the diurnal variation of plasma levels of glucose, free fatty acids, triglycerides and cholesterol and of urinary excretion of catecholamines K.F. Gey, L.A. Carlson, Metabolic Effects of Nicotinic Acid and its Derivatives 1971 Hanss Huber Publishers Bern 167 181
13. J.M. King, J.R. Crouse, J.G. Terry, T.M. Morgan, B.J. Spray, N.E. Miller Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia Am J Med 97 1994 323 331
14. J.H. O'Keefe Jr, W.S. Harris, J. Nelson, S.L. Windsor Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia Am J Cardiol 76 1995 480 484
15. L.A. Carlson, L. Oro, J. Ostman Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment J Atheroscler Res 8 1968 667 677
16. L.A. Carlson, L. Oro, J. Ostman Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia Acta Med Scand 183 1968 457 465
17. E.P. Plaisance, M.L. Mestek, A.J. Mahurin, J.K. Taylor, J. Moncada-Jimenez, P.W. Grandjean Postprandial triglyceride responses to aerobic exercise and extended-release niacin Am J Clin Nutr 88 2008 30 37
18. The Coronary Drug Project Research Group Clofibrate and niacin in coronary heart disease JAMA 231 1975 360 381
19. P.L. Canner, K.G. Berge, N.K. Wenger Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin J Am Coll Cardiol 8 1986 1245 1255
20. The AIM-HIGH Investigators W.E. Boden, J.L. Probstfield, T. Anderson et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
21. HPS2-Thrive: a randomized trial of the long-term clinical effects of raising HDL cholesterol with extended-release niacin/laropiprant http://www.thrivestudy.org Accessed June 8, 2012
22. M.C. Cabezas, T.W. de Bruin, H. Jansen, L.A. Kock, W. Kortlandt, D.W. Erkelens Impaired chylomicron remnant clearance in familial combined hyperlipidemia Arterioscler Thromb 13 1993 804 814
23. D. Lairon, J. Lopez-Miranda, C. Williams Methodology for studying postprandial lipid metabolism Eur J Clin Nutr 61 2007 1145 1161
24. R.S. Birjmohun, B.A. Hutten, J.J.P. Kastelein, E.S.G. Stroes Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials J Am Coll Cardiol 45 2005 185 197
25. W. Insull Jr, M.E. McGovern, H. Schrott Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis Arch Intern Med 164 2004 1121 1127
26. G.L. Vega, N.B. Cater, S. Meguro, S.M. Grundy Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia Am J Cardiol 95 2005 1309 1313
27. H. Florez, A. Mendez, P. Casanova-Romero Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population Atherosclerosis 188 2006 134 141
28. K.E. Friday, S.R. Srinivasan, A. Elkasabany Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men Metabolism 48 1999 749 754
29. A.J. van Oostrom, W.J. van, M.C. Cabezas Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis Drugs 64 Suppl 2 2004 19 41
30. K. Fredrik Postprandial lipemia-effect of lipid-lowering drugs Atheroscler Suppl 3 2002 41 46
31. C.M. Cabezas, D.W. Erkelens, L.A. Kock, T.W. de Bruin Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides Eur J Clin Invest 24 1994 669 678
32. L.A. Carlson Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro Acta Med Scand 173 1963 719 722
33. S. Tunaru, J. Kero, A. Schaub PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat Med 9 2003 352 355
34. A. Wise, S.M. Foord, N.J. Fraser Molecular identification of high and low affinity receptors for nicotinic acid J Biol Chem 278 2003 9869 9874
35. T. Soga, M. Kamohara, J. Takasaki Molecular identification of nicotinic acid receptor Biochem Biophys Res Commun 303 2003 364 369
36. L.A. Carlson, L. Oro The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis Acta Med Scand 172 1962 641 645
37. W. Wang, A. Basinger, R.A. Neese Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production Am J Physiol Endocrinol Metab 280 2001 E540 E547
38. L.A. Carlson Nicotinic acid: the broad-spectrum lipid drug A 50th anniversary review J Intern Med 258 2005 94 114
39. M. Lukasova, J. Hanson, S. Tunaru, S. Offermanns Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials Trends Pharmacol Sci 32 2011 700 707
40. S.M. Grundy, H.Y. Mok, L. Zech, M. Berman Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man J Lipid Res 22 1981 24 36
41. S.H. Ganji, S. Tavintharan, D. Zhu, Y. Xing, V.S. Kamanna, M.L. Kashyap Niacin non-competitively inhibits diacylglycerol acyltransferase-2 (DGAT2) but not DGAT1 activity in HepG2 cells J Lipid Res 45 2004 1835 1845
42. C. Hernandez, M. Molusky, Y. Li, S. Li, J.D. Lin Regulation of hepatic ApoC3 expression by PGC-1beta mediates hypolipidemic effect of nicotinic acid Cell Metab 12 2010 411 419
43. G. Bengtsson, T. Olivecrona Lipoprotein lipase Mechanism of product inhibition Eur J Biochem 106 1980 557 562
44. J.M. Miles, M.W. Haymond, S.L. Nissen, J.E. Gerich Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man J Clin Invest 71 1983 1554 1561
45. B. Lauring, A.K. Taggart, J.R. Tata Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression Sci Transl Med 2012 (in press)
46. S. Klein, V.R. Young, G.L. Blackburn, B.R. Bistrian, R.R. Wolfe Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects J Clin Invest 78 1986 928 933
47. A.D. Sniderman, K. Cianflone Substrate delivery as a determinant of hepatic apoB secretion Arterioscler Thromb 13 1993 629 636
48. R.H. Knopp, P. Alagona, M. Davidson Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia Metabolism 47 1998 1097 1104
49. G. Schlierf, E. Dorow Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis J Clin Invest 52 1973 732 740
50. R.L. Dunbar, J.M. Gelfand Seeing red: flushing out instigators of niacin-associated skin toxicity J Clin Invest 120 2010 2651 2655
51. A.J. van Oostrom, H. van Dijk, C. Verseyden Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3 Am J Clin Nutr 79 2004 510 515